News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
PharmaSGP Holding SE proposes a significant increase in dividend to EUR 1.36 per share for 2023, totaling EUR 16,320,000.00. The company plans to adjust its dividend policy for future distributions -
-
PRESS RELEASE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024 -
-
-
-
-
Non-Profit Organization is Seeking Host Families for Exchange Students From Highly Competitive Merit-Based Scholarship Programs
-
Revolutionizing Fire Camps: NUE's Sustainable Power Solutions Shine at USDA Technology & Development Center
-
Save A Train Continues to Innovate with Rail Enrichment
-
Cameron Ashley Building Products Opens Third Location in the Badger State
-
Event Tickets Center is Named Official Secondary Ticketing Reseller Partner for Most Valuable Promotions and the Historic Jake Paul vs. Mike Tyson Fight
-
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
-
secunet Security Networks AG successfully holds Annual General Meeting – Broad approval for all proposed resolutions
-
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
AngloGold Ashanti US$9.0m (A$13.5m) Gold Farm-in Agreement
-
2024 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
PR – ICADE – Success of the cash tender offer for a total amount of €350 million
-
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
-
Availability of preparatory documents for the annual general meeting of June 13, 2024
-
Safran’s 2024 Annual General Meeting